Aarti Drugs Ltd

Aarti Drugs Other Announcement

The company submitted its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI Listing Regulations.

Aarti Drugs Other Announcement

Aarti Drugs has updated its list of authorized personnel for determining materiality of events and making stock exchange disclosures, effective October 1, 2026.

Aarti Drugs Other Announcement

Aarti Drugs Ltd has submitted its quarterly shareholding pattern in compliance with Regulation 31(1)(b) of SEBI (LODR) Regulations for the quarter ended June 30, 2026.

Aarti Drugs Other Announcement

Aarti Drugs Ltd has filed its quarterly shareholding pattern for the period ending June 30, 2026, in compliance with SEBI regulations.

Aarti Drugs Other Announcement

Aarti Drugs Limited submitted a compliance certificate for the quarter ended March 31, 2026, regarding the dematerialisation of securities. The certificate, issued by MUFG Intime India, confirms that security certificates received were processed and listed on exchanges within prescribed timelines. This is a routine regulatory disclosure.

Aarti Drugs Other Announcement

Aarti Drugs Ltd launched the 'Saksham Niveshak' campaign from April to July 2026, following MCA guidelines. The initiative encourages shareholders to update KYC details to claim unpaid dividends before they transfer to the IEPF. This improves investor relations and ensures compliance with dividend distribution regulations.

Execution

April 1, 2026 to July 9, 2026